✦ LIBER ✦

Regional and seasonal influence in patient’s toxicity to adjuvant chemotherapy for early breast cancer

✍ Scribed by Juan de la Haba-Rodríguez; Álvaro Rodríguez-Lescure; Amparo Ruiz; Emilio Alba; Lourdes Calvo; Eva Carrasco; Maria Jose Escudero; Miguel Martín

Publisher: Springer US
Year: 2010
Tongue: English
Weight: 154 KB
Volume: 125
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-010-1136-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Assessment of highly angiogenic and diss

Assessment of highly angiogenic and disseminated in the peripheral blood disease in breast cancer patients predicts for resistance to adjuvant chemotherapy and early relapse

✍ Alexandra Giatromanolaki; Michael I. Koukourakis; Stelios Kakolyris; Dimitris Ma 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 118 KB 👁 1 views

## Abstract The assessment of tumor molecular features in combination with the detection of occult malignant cells may provide important clinical information, beyond the standard staging of breast cancer. Using a nested RT‐PCR technique, we assessed prospectively the presence of cytokeratin‐19 (CK1

Smaller regional volumes of gray and whi

Smaller regional volumes of gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy

✍ Michael H. R. Eichbaum; Andreas Schneeweiss; Christof Sohn 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 35 KB 👁 1 views

Smaller regional volumes of brain gray a

Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy

✍ Masatoshi Inagaki; Eisho Yoshikawa; Yutaka Matsuoka; Yuriko Sugawara; Tomohito N 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB 👁 1 views

Wide-field radiation as adjunct to adjuv

Wide-field radiation as adjunct to adjuvant chemotherapy in high-risk cases with early breast cancer: Do it or not?

✍ J. Ragaz; J.J. Spinelli 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 42 KB 👁 2 views

Randomized adjuvant trial to evaluate th

Randomized adjuvant trial to evaluate the addition of tamoxifen and PSK to chemotherapy in patients with primary breast cancer: 5-year results from the nishi-nippon group of the adjuvant chemoendocrine therapy for breast cancer organization

✍ Masakazu Toil; Takao Hattori; Masanobu Akagi; Kiyoshi Lnokuchi; Kunzo Orita; Kei 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 714 KB

Background. A randomized adjuvant trial was conducted from October 1982 to January 1985 to evaluate the addition of tamoxifen (TAM) to combination chemotherapy with perioperative mitomycin C (MMC) and ftorafur (FT) for patients with estrogen receptor (ER)-positive tumors and the addition of PSK, a b